AcuityMD review

AcuityMD is a MedTech intelligence platform for finding commercial opportunities and guiding sales activity. It brings together market sizing, prospect targeting, territory planning, pipeline visibility, and forecasting rather than presenting itself as a general-purpose CRM or marketing suite.

The listed tools are aimed at specific sales planning jobs: estimate opportunity by code, strategy, and region; identify accounts and prospects; align territories around high-value opportunities; and track pipeline and forecast revenue. AcuityMD also describes care journeys for uncovering referral pathways, plus Rep AI actions that suggest next steps to help reps prioritize opportunities.

That scope may suit teams selling medical devices or other MedTech products, but the available material does not explain data sources, coverage by specialty or geography, or how recommendations are generated. Buyers should verify those details against their target markets before treating an opportunity score or next-best action as a reliable sales signal.

AcuityMD’s clearest strength is its focus on commercial planning for MedTech. The feature set connects several jobs that sales leaders may otherwise handle across separate tools: sizing a market, finding accounts, assigning territories, tracking pipeline, and forecasting revenue. That makes the product’s purpose easier to assess than a broad platform pitched at every kind of sales team.

The listed capabilities include:

• Market sizing: Explore opportunities by code, strategy, and region.
• Prospect targeting: Identify high-value prospects and accounts.
• Territory planning: Align coverage around high-value opportunities.
• Care journeys: Find referral pathways.
• Pipeline and forecasting: Support pipeline visibility and revenue planning.
• Rep AI actions: Surface suggested next steps to help reps prioritize opportunities.

For a team evaluating a switch, that combination could be useful if its current stack separates market intelligence from day-to-day sales planning. But the published materials do not establish how these tools compare with a buyer’s current system, what integrations are available, or whether every feature is included in the same package. Those are questions to settle with AcuityMD before building a migration case.

The buying case is hard to price from public information. The pricing page does not publish a starting price, plan names, monthly or annual billing terms, or add-on costs. It also does not provide a free trial, and the published material lists no free plan. That leaves buyers unable to compare total cost with an incumbent tool or estimate the cost of expanding seats and coverage.

Plan limits and caps are not published in the available material either. We cannot confirm seat allowances, territory or account limits, data access limits, or which features sit behind particular packages. Ask for those details in writing, along with implementation and renewal terms, before comparing quotes.

There is little independent user feedback in the Reddit discussion we read: the only item is a remote-job listing, not a product discussion or review. The available description also does not specify data coverage, integrations, or how Rep AI actions are produced. AcuityMD may fit a focused MedTech sales workflow, but buyers still need answers on price, coverage, and operational fit.

AcuityMD does not publish plan prices, so we can’t compare tiers or calculate the cost of a switch from the available pricing information. The pricing data checked on November 7, 2026, lists no plans, add-ons, starting price, or free trial. It also says monthly and annual billing details are not published.

That leaves basic buying questions unanswered: whether pricing depends on seats, data access, product modules, or contract size; whether implementation costs extra; and what renewal terms apply. None of those details are provided in the published material. There is no published tier jump to assess, and no listed add-ons to price in.

AcuityMD’s product covers market sizing, prospect targeting, territory planning, care journeys, pipeline, forecasting, and AI-powered rep actions. But feature breadth does not tell us what a package includes or what it costs. Before comparing it with another sales intelligence platform, ask for a written quote that separates subscription, setup, data, and renewal costs. Treat any budget estimate as unverified until AcuityMD provides one.

The published material does not document AcuityMD’s onboarding process, migration tools, data-export formats, or contract terms. We can’t say how much work a move would take, whether records can be exported in bulk, or what happens to historical territory and pipeline data when a contract ends. Ask AcuityMD for those details before signing, and get export rights and transition support in writing.

AcuityMD is built for MedTech commercial teams, with tools for market sizing, targeting, territories, care journeys, pipeline, and forecasting. Moving to it may involve mapping existing account, territory, and opportunity data to those workflows; the available sources do not specify whether AcuityMD handles that work or charges for it. Moving away could require rebuilding those workflows elsewhere, but the published material does not describe a documented lock-in mechanism.

The published research includes no specific Reddit reports about why customers leave, migration pain, or data access. User feedback is described as scant, so we can’t present a recurring reason for switching as established. Ask for a sample export and a clear exit process during evaluation.